[Intermittent claudication: review of a disease of growing prevalence. II. Treatment].
Riambau
V
V
Servicio de Cirugía Cardíaca y Vascular, Hospital Clínic i Provincial, Barcelona.
Piñol
C
C
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D019917:Blood Vessel Prosthesis Implantation; D002986:Clinical Trials as Topic; D015444:Exercise; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010431:Pentoxifylline / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D011453:Prostaglandins / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D012307:Risk Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D010726:Phosphodiesterase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins; D011759:Pyrrolidines; D014665:Vasodilator Agents; D010431:Pentoxifylline; C010651:buflomedil
Claudicación intermitente: revisión de una enfermedad de prevalencia creciente (II). Tratamiento.